Top Markets
Coin of the day
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rangering i aksjer #28283
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Aksjekurs
$0.3958979
Markedsverdi
$27.40M
Endring (1 dag)
-0.40%
Endring (1 år)
-48.96%
Land
TW
Handel LAUNXP Biomedical Co., Ltd (6876)

Kategori

P/B-forhold for LAUNXP Biomedical Co., Ltd (6876)
P/B-forhold per 2026 TTM: 0
Ifølge LAUNXP Biomedical Co., Ltd sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for LAUNXP Biomedical Co., Ltd fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH